STE vs PODD — Key Metrics

Metric STE (STERIS PLC) PODD (INSULET CORP)
Price259.57139.98
Market Cap25.21 Billion9.71 Billion
P/E (TTM)30.6822.8
P/B (Quarterly)3.47.249
P/S (TTM)4.093.04
Net Profit Margin (TTM)13.413.4
Gross Margin (TTM)44.671.9
ROE (TTM)11.529.5
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

STERIS PLC
vs
 
INSULET CORP
 
STERIS PLC
vs
 
INSULET CORP
Performance Comparison
AI Model Recommendation
STE · STERIS PLC

Greatly Underperform

-92
UnderperformOutperform
PODD · INSULET CORP

Outperform

47
UnderperformOutperform
Recommendation Summary

Stock STE is projected to greatly underperform the market, stock PODD is projected to outperform the market. Upfront Recommendation: PODD.

Financial Metrics
Prices delayed ~15 min
STE Metrics PODD
$259.57 Price $139.98
— Market Capitalization —
30.68 Price to Earnings Ratio 22.8
4.09 Price to Sales 3.04
26.6 Price to FCF Ratio 41.75
9.17 Price to Gross Profit 4.24
212.89 Price to R&D 26.95
10.17 Price to Current Assets 4.76

STE vs PODD at a glance

Steris PLC (STE) and Insulet Corp (PODD) are both Medical Devices companies in the Healthcare sector. STE is the larger, at $25.2 billion in market value against $9.7 billion for PODD, about 2.6 times the size.

On trailing-twelve-month figures, STE trades at 30.7 times trailing earnings and PODD at 22.8; net profit margins are 13.4% and 13.4%.

The Upfront Investment model currently rates STE Greatly Underperform and PODD Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.